|
1
|
Sawyer TK, Shakespeare WC, Wang Y, et al:
Protein phosphorylation and signal transduction modulation:
chemistry perspectives for small-molecule drug discovery. Med Chem.
1:293–319. 2005. View Article : Google Scholar
|
|
2
|
Brown MD and Sacks DB: Protein scaffolds
in MAP kinase signalling. Cell Signal. 21:462–469. 2009. View Article : Google Scholar :
|
|
3
|
Rana A, Rana B, Mishra R, et al: Mixed
lineage kinase-c-Jun N-terminal kinase axis: a potential
therapeutic target in cancer. Genes Cancer. 4:334–341. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fischer S, Koeberle SC and Laufer SA: p38α
mitogen-activated protein kinase inhibitors, a patent review
(2005–2011). Expert Opin Ther Pat. 21:1843–1866. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cohen P: The search for physiological
substrates of MAP and SAP kinases in mammalian cells. Trends Cell
Biol. 7:353–361. 1997. View Article : Google Scholar
|
|
6
|
Borders AS, de Almeida L, Van Eldik LJ and
Watterson DM: The p38alpha mitogen-activated protein kinase as a
central nervous system drug discovery target. BMC Neurosci. 9(Suppl
2): S122008. View Article : Google Scholar
|
|
7
|
Xia Z, Dickens M, Raingeaud J, Davis RJ
and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases
on apoptosis. Science. 270:1326–1331. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zechner D, Craig R, Hanford DS, McDonough
PM, Sabbadini RA and Glembotski CC: MKK6 activates myocardial cell
NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein
kinase-dependent manner. J Biol Chem. 273:8232–8239. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Remacle-Bonnet MM, Garrouste FL, Heller S,
André F, Marvaldi JL and Pommier GJ: Insulin-like growth factor-I
protects colon cancer cells from death factor-induced apoptosis by
potentiating tumor necrosis factor alpha-induced mitogen-activated
protein kinase and nuclear factor kappaB signaling pathways. Cancer
Res. 60:2007–2017. 2000.PubMed/NCBI
|
|
10
|
Zidi I, Mestiri S, Bartegi A and Amor NB:
TNF-alpha and its inhibitors in cancer. Med Oncol. 27:185–198.
2010. View Article : Google Scholar
|
|
11
|
Szlosarek PW and Balkwill FR: Tumour
necrosis factor alpha: a potential target for the therapy of solid
tumours. Lancet Oncol. 4:565–573. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gray-Schopfer VC, Karasarides M, Hayward R
and Marais R: Tumor necrosis factor-alpha blocks apoptosis in
melanoma cells when BRAF signaling isinhibited. Cancer Res.
67:122–129. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun SY, Yue P, Hong WK and Lotan R:
Augmentation of tumor necrosis factor-related apoptosis-inducing
ligand (TRAIL)-induced apoptosis by the synthetic retinoid
6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid
(CD437) through up-regulation of TRAIL receptors in human lung
cancer cells. Cancer Res. 60:7149–7155. 2000.
|
|
14
|
Barbin G, Roisin M and Zalc B: Tumor
necrosis factor α activates the phosphorylation of ERK, SAPK/JNK,
and P38 kinase in primary cultures of neurons. Neurochem Res.
26:107–112. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Valladares A, Alvarez AM, Ventura JJ,
Roncero C, Benito M and Porras A: p38 mitogen-activated protein
kinase mediates tumor necrosis factor-alpha-induced apoptosis in
rat fetal brown adipocytes. Endocrinology. 141:4383–4395.
2000.PubMed/NCBI
|
|
16
|
Lüschen S, Scherer G, Ussat S, Ungefroren
H and Adam-Klages S: Inhibition of p38 mitogen-activated protein
kinase reduces TNF-induced activation of NF-kappaB, elicits caspase
activity, and enhances cytotoxicity. Exp Cell Res. 293:196–206.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ricote M, García-Tuñón I, Fraile B,
Fernández C, Aller P, Paniagua R and Royuela M: P38 MAPK protects
against TNF-alpha-provoked apoptosis in LNCaP prostatic cancer
cells. Apoptosis. 11:1969–1975. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang X, Yao J, Luo Y, Han Y, Wang Z and Du
L: P38 MAP kinase mediates apoptosis after genipin treatment in
non-small-cell lung cancer H1299 cells via a mitochondrial
apoptotic cascade. J Pharmacol Sci. 121:272–281. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bradford MM: A rapid and sensitive for the
quantitation of microgram quantitites of protein utilizing the
principle of protein-dye binding. Analytical Biochemistry.
72:248–254. 1976. View Article : Google Scholar
|
|
20
|
Allegra A, Alonci A, Campo S, Penna G,
Petrungaro A, Gerace D and Musolino C: Circulating microRNAs: new
biomarkers in diagnosis, prognosis and treatment of cancer
(review). Int J Oncol. 41:1897–1912. 2012.PubMed/NCBI
|
|
21
|
Yin D, Kondo S, Barnett GH, Morimura T and
Takeuchi J: Tumor necrosis factor-alpha induces p53-dependent
apoptosis in rat glioma cells. Neurosurgery. 37:758–763. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Han J, Lee JD, Bibbs L and Ulevitch RJ: A
MAP kinase targeted by endotoxin and hyperosmolarity in mammalian
cells. Science. 265:808–811. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ashwell JD: The many paths to p38
mitogen-activated protein kinase activation in the immune system.
Nat Rev Immunol. 6:532–540. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cuadrado A and Nebreda AR: Mechanisms and
functions of p38 MAPK signalling. Biochem J. 429:403–17. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ishii A, Furusho M and Bansal R: Sustained
activation of ERK1/2 MAPK in oligodendrocytes and schwann cells
enhances myelin growth and stimulates oligodendrocyte progenitor
expansion. J Neurosci. 33:175–186. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park MT, Choi JA, Kim MJ, et al:
Suppression of extracellular signal-related kinase and activation
of p38 MAPK are two critical events leading to caspase-8- and
mitochondria-mediated cell death in phytosphingosine-treated human
cancer cells. J Biol Chem. 278:50624–50634. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mandal C, Dutta A, Mallick A, Chandra S,
Misra L, Sangwan RS and Mandal C: Withaferin A induces apoptosis by
activating p38 mitogen-activated kinase signaling cascade in
leukemic cells of lymphoid and myeloid origin through mitochondrial
death cascade. Apoptosis. 13:1450–1464. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ozaki I, Tani E, Ikemoto H, Kitagawa H and
Fujikawa H: Activation of stress-activated protein kinase/c-Jun
NH2-terminal kinase and p38 kinase in calphostin C-induced
apoptosis requires caspase-3-like proteases but is dispensable for
cell death. J Biol Chem. 274:5310–5317. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kanagasabai R, Karthikeyan K, Vedam K,
Qien W, Zhu Q and Ilangovan G: Hsp27 protects adenocarcinoma cells
from UV-induced apoptosis by Akt and p21-dependent pathways of
survival. Mol Cancer Res. 8:1399–1412. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park JG, Yuk Y, Rhim H, Yi SY and Yoo YS:
Role of p38 MAPK in the regulation of apoptosis signaling induced
by TNF-alpha in differentiated PC12 cells. J Biochem Mol Biol.
35:267–272. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun CL and Chao CC: Potential attenuation
of p38 signaling by DDB2 as a factor in acquired TNF resistance.
Int J Cancer. 115:383–387. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin CY, Chang SL, Fong YC, Hsu CJ and Tang
CH: Apoptosis signal-regulating kinase 1 is involved in
brain-derived neurotrophic factor (BDNF)-enhanced cell motility and
matrix metalloproteinase 1 expression in human chondrosarcoma
cells. Int J Mol Sci. 14:15459–15478. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Won M, Park KA, Byun HS, et al: Novel
anti-apoptotic mechanism of A20 through targeting ASK1 to suppress
TNF-induced JNK activation. Cell Death Differ. 17:1830–1841. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Morita Y, Naka T, Kawazoe Y, et al:
Signals transducers and activators of transcription (STAT)-induced
STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1
(SOCS-1) suppresses tumor necrosis factor alpha-induced cell death
in fibroblasts. Proc Natl Acad Sci USA. 97:5405–5410. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Noguchi K, Yamana H, Kitanaka C, Mochizuki
T, Kokubu A and Kuchino Y: Differential role of the JNK and p38
MAPK pathway in c-Myc- and s-Myc-mediated apoptosis. Biochem
Biophys Res Commun. 267:221–227. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cho SD, Ahn NS, Jung JW, et al: Critical
role of the c-JunNH2-terminal kinase and p38 mitogen-activated
protein kinase pathways on sodium butyrate-induced apoptosis in
DU145 human prostate cancer cells. Eur J Cancer Prev. 15:57–63.
2006. View Article : Google Scholar
|
|
37
|
Van Laethem A, Van Kelst S, Lippens S, et
al: Activation of p38 MAPK is required for Bax translocation to
mitochondria, cytochrome c release and apoptosis induced by UVB
irradiation in human keratinocytes. FASEB J. 18:1946–1948.
2004.PubMed/NCBI
|
|
38
|
Keller D, Zeng X, Li X, et al: The p38MAPK
inhibitor SB203580 alleviates ultraviolet-induced phosphorylation
at serine 389 but not serine 15 and activation of p53. Biochem
Biophys Res Commun. 261:464–471. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bhat NR, Zhang PS, Lee JC and Hogan EL:
Extracellular signal-regulated kinase and p38 subgroups of
mitogen-activated protein kinases regulate inducible nitric oxide
synthase and tumor necrosis factor-alpha gene expression in
endotoxin-stimulated primary glial cultures. J Neurosci.
18:1633–1641. 1998.PubMed/NCBI
|
|
40
|
Donnahoo KK, Shames BD, Harken AH and
Meldrum DR: Review article: the role of tumor necrosis factor in
renal ischemia-reperfusion injury. J Urol. 162:196–203. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ichijo H, Nishida E, Irie K, et al:
Induction of apoptosis by ASK1, a mammalian MAPKKK that activates
SAPK/JNK and p38 signaling pathways. Science. 275:90–94. 1997.
View Article : Google Scholar : PubMed/NCBI
|
